ketamine has been researched along with Atypical Lipomatous Tumor in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a case of opioid-refractory pain that responded to a low-dose IV infusion of ketamine in the inpatient setting." | 1.35 | Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient. ( Fitzgibbon, DR; Grande, LA; O'Donnell, BR; Terman, GW, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bornemann-Cimenti, H | 1 |
| Dorn, C | 1 |
| Rumpold-Seitlinger, G | 1 |
| Grande, LA | 1 |
| O'Donnell, BR | 1 |
| Fitzgibbon, DR | 1 |
| Terman, GW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Memantine for Post-Operative Pain Control[NCT01041313] | Phase 4 | 120 participants (Anticipated) | Interventional | 2010-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for ketamine and Atypical Lipomatous Tumor
| Article | Year |
|---|---|
Early Onset and Treatment of Phantom Limb Pain Following Surgical Amputation.
Topics: Aged; Amputation, Surgical; Analgesics; Anesthetics, Local; Calcitonin; Early Medical Intervention; | 2017 |
Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
Topics: Adult; Analgesics; Analgesics, Opioid; Drug Tolerance; Humans; Ketamine; Liposarcoma; Male; Memantin | 2008 |